Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis-Reference-Cited by-同舟云学术

Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis

Published:2009-05-04 Issue:10 Volume:182 Page:5909-5913
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Coisne Caroline,Mao Wenxian,Engelhardt Britta

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference16 articles.

1. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

2. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms

3. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

4. Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

5. VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restricting CAR T Cell Trafficking Expands Targetable Antigen Space;2024-02-11

2. The blood-brain barrier in multiple sclerosis;Mechanisms of Disease Pathogenesis in Multiple Sclerosis;2024

3. Learning CNS immunopathology from therapeutic interventions;Science Translational Medicine;2023-11-08

4. Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions;Frontiers in Molecular Neuroscience;2023-09-25

5. High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro;Journal of Neuroinflammation;2023-05-23